Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 2, 2004, Pages 180-188

  Gootjes, L ^a,c   Teipel, S J ^a   Zebuhr, Y ^a   Schwarz, R ^a   Leinsinger, G ^b   Scheltens, P ^d   Moller H J ^a   Hampel, H ^a  

^a Alzheimer Memorial Center   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Magnetic resonance imaging; Neuropsychology; White matter

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CASE REPORT; COGNITION; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FRONTAL LOBE; HUMAN; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELIABILITY; VOLUMETRY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN MAPPING; DEMENTIA, VASCULAR; FEMALE; FRONTAL LOBE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; NERVE FIBERS, MYELINATED; NETHERLANDS; OCCIPITAL LOBE; PARIETAL LOBE; PSYCHOMETRICS; REFERENCE VALUES;

EID: 4344623368     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079199     Document Type: Article

References (51)

1. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlations with age and cerebrovascular risk factors. Stroke 1986;17:1084-1089.
2. Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E: The spectrum of age-associated brain abnormalities: Their measurement and histopathological correlates. J Neural Transm Suppl 1998;53:31-39.
3. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W: Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995;45:883-888.
4. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, et al: White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
5. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994;44:1246-1252.
6. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al: Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
7. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski V: Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 1994;51:260-268.
8. Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G: The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurol Sci 1996;142:121-125.
9. Awad IA, Johnson PC, Spetzler RF, Hodak JA: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke 1986;17:1090-1097.
10. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gillette JA, et al: The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
11. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson LA: The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand 1996;93:142-148.
12. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R: White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-824.
13. Almkvist O, Wahlund L-O, Andersson-Lundman G, Basun H, Bäckman L: White-matter-hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-632.
14. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM: Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 2001;56:1539-1545.
15. Hunt AL, Orrison WW, Yeo RA, Haaland KY, Rhyne RL, Garry PJ, et al: Clinical significance of MRI white matter lesions in the elderly. Neurology 1989;39:1470-1474.
16. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ: Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry 2000;15:803-812.
17. Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, et al: Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002;59:383-391.
18. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E: Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study. Stroke 2000;31:2182-2188.
19. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, et al: MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001;57:2229-2235.
20. Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, et al: Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002;59:867-873.
21. Van der Werf YD, Witter MP, Uylings HB, Jolles J: Neuropsychology of infarctions in the thalamus: A review. Neuropsychologia 2000;38:613-627.
22. Mineura K, Sasajima H, Kikuchi K, Kowada M, Tomura N, Monma K, et al: White matter hyperintensity in neurologically asymptomatic subjects. Acta Neurol Scand 1995;92:151-156.
23. Moody DM, Bell MA, Challa VR: Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study. AJNR Am J Neuroradiol 1990;11:431-439.
24. Ishii N, Nishihara Y, Imamura T: Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986;36:340-345.
25. Morris JH: Vascular dementia; in Esiri MM, Morris JH (eds): The Neuropathology of Dementia. Cambridge, Cambridge University Press, 1997, pp 137-171.
26. Yamanouchi H, Sugiura S, Tomonaga M: Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. J Neurol 1989;236:382-387.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
28. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
29. Folstein MF, Folstein SE, McHugh PR: Mini-mental-state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
30. Bokde AL, Teipel SJ, Zebuhr Y, Leinsinger G, Gootjes L, Schwarz R, et al: A new rapid landmark-based regional MRI segmentation method of the brain. J Neurol Sci 2002;194:35-40.
31. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC: Automated image registration. I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998;22:141-154.
32. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
33. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
34. Mantyla R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, et al: Variable agreement between visual rating scales for white matter hyperintensities on MRI: Comparison of 13 rating scales in a poststroke cohort. Stroke 1997;28:1614-1623.
35. Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, del Ser T, et al: White matter changes on CT and MRI: An overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80-89.
36. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJP, Vermersch P, et al: A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7-12.
37. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-1322.
38. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, et al: FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001;14:668-676.
39. Schmidt R: Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992;32:164-169.
40. Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop GR, Nauta J, et al: White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: Evidence for heterogeneity. Brain 1992;115:735-748.
41. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weathers S: Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993;56:182-187.
42. 99mTc-HMPAO SPET study. Eur J Nucl Med 1996;23:1338-1344.
43. Hanyu H, Imon Y, Sakurai H, Iwamoto T, Takasaki M, Shindo H, et al: Regional differences in diffusion abnormality in cerebral white matter lesions in patients with vascular dementia of the Binswanger type and Alzheimer's disease. Eur J Neurol 1999;6:195-203.
44. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986;19:253-262.
45. Yamanouchi H, Sugiura S, Shimada H: Decrease of nerve fibres in the anterior corpus callosum of senile dementia of Alzheimer type. J Neurol 1989;236:491-492.
46. Villa G, Gainotti G, De Bonis C: Constructive disabilities in focal brain-damaged patients: Influence of hemispheric side, locus of lesion and coexistent mental deterioration. Neuropsychologia 1986;24:497-510.
47. Cohen RA, Paul RH, Ott BR, Moser DJ, Zawacki TM, Stone W, et al: The relationship of subcortical MRI hyperintensities and brain volume to cognitive function in vascular dementia. J Int Neuropsychol Soc 2002;8:743-752.
48. Teipel SJ, Hampel H, Alexander GE, Schapiro MB, Horwitz B, Teichberg D, et al: Dissociation between white matter pathology and corpus callosum atrophy in Alzheimer's disease. Neurology 1998;51:1381-1385.
49. Crowe SF: Dissociation of two frontal lobe syndromes by a test of verbal fluency. J Clin Exp Neuropsychol 1992;14:327-339.
50. Yamauchi H, Fukuyama H, Shio H: Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment. Stroke 2000;31:1515-1520.
51. Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O: Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 1994;35:117-122.